捷邦科技(301326.SZ):公司具備向大客户提供MR設備的精密功能件研發、製造能力
格隆匯6月5日丨有投資者在投資者互動平台向捷邦科技(301326.SZ)提問,“公司在虛擬現實、混合現實有什麼探索和應用?蘋果新品對公司有何影響?”
公司回覆稱,公司具備向大客户提供MR設備的精密功能件研發、製造能力。就MR領域客户拓展情況,由於公司與客户簽署保密協議,具體合作約定暫不便透露。此外,公司是蘋果公佈的2018財年和2020財年-2022財年全球主要供應商,公司與蘋果保持深度合作,其平板電腦、筆記本電腦、一體機電腦產品是公司重要的定製化服務對象,該類產品終端出貨量與公司業績具有較大的正向相關性。但由於蘋果開發者大會發布的產品信息並未有官方公佈,基於公司和客户簽署的保密協議,涉及具體合作約定暫不便透露。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.